1. Dr. Giuseppe Curigliano. Expertin für Brustkrebstherapie. Biografie. 0
Dr. Giuseppe Curigliano, MD, explains the latest advances in treating HER2-positive, HER2-negative, and triple-negative breast cancer. He details the role of immunotherapy and the challenges...
▶⏸
2. Gezielte Therapie bei Brustkrebs. Was sind die molekularen Angriffspunkte von Medikamenten? 1
Dr. Giuseppe Curigliano, MD, explains how targeted therapies are revolutionizing breast cancer treatment by attacking specific molecular targets. He details the latest breakthroughs in CDK4/6...
▶⏸
3. Präzisionsmedizin in der Brustkrebstherapie. Zielgerichtete Medikamente oder Chemotherapie? 2
Dr. Giuseppe Curigliano, MD, explains how new targeted therapies and genomic tests are transforming early-stage treatment. He details the significant survival benefits of adding immunotherapy...
Dr. Giuseppe Curigliano, MD, explains the latest advances in treating hormone receptor-positive, HER2-negative breast cancer. He details the use of PI3K alpha inhibitors like alpelisib...
Dr. Giuseppe Curigliano, MD, explains the latest advancements in treating this aggressive breast cancer subtype. He details the significant role of new agents like the...
Dr. Giuseppe Curigliano, MD, explains the latest treatment advances for triple-negative breast cancer, including immunotherapy, antibody-drug conjugates, and PARP inhibitors. He details the critical role...
Dr. Giuseppe Curigliano, MD, explains how patient selection based on the tumor's immunological profile is critical for success. He details the significant benefits of using...
▶⏸
8. Nebenwirkungen der Immuntherapie bei Brustkrebspatientinnen. 7
Dr. Giuseppe Curigliano, MD, explains the most common side effects of immune checkpoint inhibitors, including cutaneous rash, hepatitis, and colitis. He details how these autoimmune...
▶⏸
9. Zukunft in der Brustkrebstherapie. Deeskalation der Behandlung. Heilung von metastasierendem Krebs? 8
Dr. Giuseppe Curigliano, MD, explains the future of treatment, focusing on three key concepts: de-escalation of therapy for low-risk patients, development of better-tolerated medications to...
Dr. Giuseppe Curigliano, MD, explains how a patient with metastatic triple-negative breast cancer achieved long-term survival for nearly a decade after treatment with a combination...
▶⏸
11. „Sie müssen der Patientin eine menschliche Note geben.“ Top-Brustkrebsexperte teilt Weisheit. 10
Dr. Giuseppe Curigliano, MD, explains the critical importance of the human touch in patient care, emphasizing that compassion and personal attention are as vital as...
▶⏸
12. test vimeo embed
Verfeinern Sie Ihren Behandlungsplan bis zur Perfektion durch ein Gremium von 3 bis 10+ Top-Ärzten, die perfekt für Sie sind.
